Health Advance (HADV) Stock Statistics & Valuation Metrics
Total Valuation
Health Advance has a market cap or net worth of $468.52K. The enterprise value is $356.36B.
- Market Cap
- $468.52K
- Enterprise Value
- $356.36B
Share Statistics
Health Advance has 1,561,719,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,561,719,700
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Health Advance’s return on equity (ROE) is 0.48 and return on invested capital (ROIC) is -37.62%.
- Return on Equity (ROE)
- 0.48
- Return on Assets (ROA)
- -0.17
- Return on Invested Capital (ROIC)
- -37.62%
- Return on Capital Employed (ROCE)
- -0.70
- Revenue Per Employee
- 0
- Profits Per Employee
- -29.07K
- Employee Count
- 3
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Health Advance is -4.39. Health Advance’s PEG ratio is -0.04.
- PE Ratio
- -4.39
- PS Ratio
- 0.00
- PB Ratio
- -2.09
- Price to FCF
- -0.86
- Price to Operating Cash Flow
- -6.82
- PEG Ratio
- -0.04
Income Statement
In the last 12 months, Health Advance had revenue of 0 and earned -87.21K in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -65.41K
- Pretax Income
- -87.21K
- Net Income
- -87.21K
- EBITDA
- -65.41K
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -56.19K and capital expenditures -5, giving a free cash flow of -56.20K billion.
- Operating Cash Flow
- -56.19K
- Free Cash Flow
- -56.20K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Health Advance pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -116.37%
- Earnings Yield
- -22.77%
Stock Price Statistics
- Beta
- -0.86
- 52-Week Price Change
- -84.85%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Health Advance as a current ratio of 0.79, with Debt / Equity ratio of -194.72%
- Current Ratio
- 0.79
- Quick Ratio
- 0.79
- Debt to Market Cap
- 0.85
- Net Debt to EBITDA
- -5.44
- Interest Coverage Ratio
- -2.71
Taxes
In the past 12 months, Health Advance has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Health Advance EV to EBITDA ratio is -6.18, with an EV/FCF ratio of -7.20.
- EV to Sales
- 0.00
- EV to EBITDA
- -6.18
- EV to Free Cash Flow
- -7.20
- EV to Operating Cash Flow
- -7.20
Balance Sheet
Health Advance has $1,282.00 in cash and marketable securities with $357.45K in debt, giving a net cash position of -$356.17K billion.
- Cash & Marketable Securities
- $1,282.00
- Total Debt
- $357.45K
- Net Cash
- -$356.17K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Health Advance is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 0.00%